Document is current
Any future updates will be listed below
-
Authors
Mo, Hongnan https://orcid.org/0000-0002-2887-7985
Yu, Yongpei
Sun, Xiaoying
Ge, Hewei https://orcid.org/0000-0002-9852-2733
Yu, Lanlan
Guan, Xiuwen
Zhai, Jingtong
Zhu, Aihua
Wei, Yuhan https://orcid.org/0000-0002-8238-4663
Wang, Jinjing
Yan, Xiaoyan
Qian, Haili https://orcid.org/0000-0003-0652-4801
Xu, Binghe https://orcid.org/0000-0003-4195-337X
- License Information
-
More Information
Article History
Received: 7 February 2024
Accepted: 24 May 2024
First Online: 5 July 2024
Competing interests
: X.B. reports personal advisory fees from Novartis and personal payment or honoraria fees for lecture from AstraZeneca, Pfizer, Roche and Eisai, outside of the submitted work. The other authors declare no competing interests.
